Ameriprise’s Amneal Pharmaceuticals AMRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $14.7M | Sell |
|
|||||
|
2025
Q2 | $13.8M | Buy |
|
|||||
|
2025
Q1 | $13.9M | Buy |
|
|||||
|
2024
Q4 | $12.2M | Sell |
|
|||||
|
2024
Q3 | $13.2M | Buy |
|
|||||
|
2024
Q2 | $68.1K | Sell |
|
|||||
|
2024
Q1 | $67.3K | Sell |
|
|||||
|
2023
Q4 | $498K | Buy |
|
|||||
|
2023
Q3 | $292K | Buy |
|
|||||
|
2023
Q2 | $51.2K | Sell |
|
|||||
|
2023
Q1 | $164K | Buy |
|
|||||
|
2022
Q4 | $172K | Buy |
|
|||||
|
2022
Q3 | $120K | Buy |
|
|||||
|
2022
Q2 | $85K | Buy |
|
|||||
|
2022
Q1 | $72K | Buy |
|
|||||
|
2021
Q4 | $82K | Sell |
|
|||||
|
2021
Q3 | $96K | Buy |
|
|||||
|
2021
Q2 | $91K | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $296K | Buy |
|
|||||
|
2020
Q2 | $230K | Sell |
|
|||||
|
2020
Q1 | $413K | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $7.08M | Sell |
|
|||||
|
2019
Q1 | $25.9M | Sell |
|
|||||
|
2018
Q4 | $25.1M | Sell |
|
|||||
|
2018
Q3 | $43M | Sell |
|
|||||
|
2018
Q2 | $50M | Buy |
|